OBJECTIVES: To assess the presence and risk factors of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among patients admitted to the University Teaching Hospital of Butare and among their attending caregivers, and to analyse the acquisition of ESBL-PE carriage during hospital stay and associated factors. METHODS: We screened 392 patients and their attending caregivers at admission and discharge for ESBL-PE carriage. Bacterial species were determined using the API-20E system, and antimicrobial susceptibility testing was performed by agar disc diffusion. Data on socio-economic status, diet, behaviour, household assets, livestock and hospital procedures were collected. RESULTS: At admission, 50% of the patients showed intestinal ESBL-PE carriage (Escherichia coli, 51%; Klebsiella pneumoniae, 39%; Enterobacter cloacae, 19%) as did 37% of their caregivers. Co-resistance was common but no carbapenem resistance was detected. At discharge, the proportion of ESBL-PE-colonised patients increased to 65% (caregivers, 47%) with almost complete carriage in paediatric patients (93%). The acquisition rate among initially non-colonised patients was 55% (or, 71/1000 patient days). Independent predictors of admission carriage included a colonised caregiver, prior antibiotic intake, egg consumption and neglecting to boil drinking water, whereas being a paediatric patient, undergoing surgery and male gender predicted acquisition during hospitalisation. CONCLUSIONS: Abundant admission carriage of ESBL-PE and a high acquisition rate in a Rwandan university hospital point to potential intrahospital transmission and community dissemination. Caregivers are an additional source of possible spread. Risk factors of colonisation such as diet and water source need to be tackled to prevent the further emergence and spread of ESBL-PE.
OBJECTIVES: To assess the presence and risk factors of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among patients admitted to the University Teaching Hospital of Butare and among their attending caregivers, and to analyse the acquisition of ESBL-PE carriage during hospital stay and associated factors. METHODS: We screened 392 patients and their attending caregivers at admission and discharge for ESBL-PE carriage. Bacterial species were determined using the API-20E system, and antimicrobial susceptibility testing was performed by agar disc diffusion. Data on socio-economic status, diet, behaviour, household assets, livestock and hospital procedures were collected. RESULTS: At admission, 50% of the patients showed intestinal ESBL-PE carriage (Escherichia coli, 51%; Klebsiella pneumoniae, 39%; Enterobacter cloacae, 19%) as did 37% of their caregivers. Co-resistance was common but no carbapenem resistance was detected. At discharge, the proportion of ESBL-PE-colonised patients increased to 65% (caregivers, 47%) with almost complete carriage in paediatric patients (93%). The acquisition rate among initially non-colonised patients was 55% (or, 71/1000 patient days). Independent predictors of admission carriage included a colonised caregiver, prior antibiotic intake, egg consumption and neglecting to boil drinking water, whereas being a paediatric patient, undergoing surgery and male gender predicted acquisition during hospitalisation. CONCLUSIONS: Abundant admission carriage of ESBL-PE and a high acquisition rate in a Rwandan university hospital point to potential intrahospital transmission and community dissemination. Caregivers are an additional source of possible spread. Risk factors of colonisation such as diet and water source need to be tackled to prevent the further emergence and spread of ESBL-PE.
Authors: Tori Sutherland; Christophe Mpirimbanyi; Elie Nziyomaze; Jean-Paul Niyomugabo; Zack Niyonsenga; Claude Mambo Muvunyi; Ariel Mueller; Lisa M Bebell; Theoneste Nkubana; Emile Musoni; Daniel Talmor; Jennifer Rickard; Elisabeth D Riviello Journal: PLoS One Date: 2019-08-23 Impact factor: 3.240
Authors: Ngure Kagia; Patrick Kosgei; Michael Ooko; Leonard Wafula; Neema Mturi; Kirimi Anampiu; Salim Mwarumba; Patricia Njuguna; Anna C Seale; James A Berkley; Christian Bottomley; J Anthony G Scott; Susan C Morpeth Journal: Clin Infect Dis Date: 2019-08-16 Impact factor: 9.079
Authors: Stefan E Heiden; Mathis S E Kurz; Jürgen Bohnert; Claude Bayingana; Jules M Ndoli; Augustin Sendegeya; Jean Bosco Gahutu; Elias Eger; Frank P Mockenhaupt; Katharina Schaufler Journal: Antimicrob Resist Infect Control Date: 2020-02-17 Impact factor: 4.887
Authors: Elias Eger; Stefan E Heiden; Katja Korolew; Claude Bayingana; Jules M Ndoli; Augustin Sendegeya; Jean Bosco Gahutu; Mathis S E Kurz; Frank P Mockenhaupt; Julia Müller; Stefan Simm; Katharina Schaufler Journal: Front Microbiol Date: 2021-05-14 Impact factor: 5.640
Authors: M J Carvalho; K Sands; K Thomson; E Portal; J Mathias; R Milton; D Gillespie; C Dyer; C Akpulu; I Boostrom; P Hogan; H Saif; A Ferreira; M Nieto; T Hender; K Hood; R Andrews; W J Watkins; B Hassan; G Chan; D Bekele; S Solomon; G Metaferia; S Basu; S Naha; A Sinha; P Chakravorty; S Mukherjee; K Iregbu; F Modibbo; S Uwaezuoke; L Audu; C P Edwin; A H Yusuf; A Adeleye; A S Mukkadas; R Zahra; H Shirazi; A Muhammad; S N Ullah; M H Jan; S Akif; J B Mazarati; A Rucogoza; L Gaju; S Mehtar; A N H Bulabula; A Whitelaw; L Roberts; T R Walsh Journal: Nat Microbiol Date: 2022-08-04 Impact factor: 30.964